Lansen Pharmaceutical Holdings Limited 朗生醫藥控股有限公司

• Key Data
• Officers
• Overlaps
• Pay
• Advisers
• Financials

Pay for financial year ended 2021-12-31

	Name	Last position	Fees	Salary & benefits	Bonus	Retire	Share- based	Total
HKD '000
	Directors
1	Chan, Michael Kee Huen 陳記煊	INED	35					35
2	Chen, Li (Lansen Pharmaceutical) 陳力	CEO		553	132	12		697
3	Horlacher, Fritz Heinrich	INED	32					32
4	Hunt, Stephen Burnau 韓仕德	NED	38					38
5	Liu, Xuezi 劉雪姿	NED		200	87	2		289
6	Wu, Zhentao 吳鎮濤	NED, Ch
7	Yeung, Allen Tak Bun 楊德斌	INED	35					35
	Total		140	753	219	14	0	1,126

Main board pay history

Click on the year-end to see the pay details.

HKD'000

Year-end	Fees	Salary & benefits	Bonus	Retire	Share- based	Total
2022-12-31	125	745	449	2	0	1,321	Report
2021-12-31	140	753	219	14	0	1,126	Report
2020-12-31	109	506	277	11	0	903	Report
2019-12-31	151	461	200	17	0	829	Report
2018-12-31	148	515	176	16	0	855	Report
2016-12-31	141	594	0	16	0	751	Report
2015-12-31	141	298	0	6	0	445	Report
2014-12-31	142	365	0	18	0	525	Report
2013-12-31	100	227	0	51	0	378	Report
2012-12-31	131	330	0	31	0	492	Report
2011-12-31	129	326	0	27	0	482	Report
2010-12-31	100	267	0	25	0	392	Report
Total	1,557	5,387	1,321	234	0	8,499

SGD'000

Year-end	Fees	Salary & benefits	Bonus	Retire	Share- based	Total
2017-12-31	141	333	110	17	0	601	Report
Total	141	333	110	17	0	601

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!

---

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top

---